國家衛生研究院 NHRI:Item 3990099045/10717
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 916516      線上人數 : 1439
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/10717


    題名: The treatment patterns of non-metastatic prostate cancer in an Asian country
    作者: Huang, EYH;Yu, HJ;Chang, YH;Wu, TT;Cha, TL;Pang, ST;Huang, SP;Pan, CC;Cheng, JCH;Hsieh, RK;Peng, RS;Ku, HY;Liu, TW
    貢獻者: National Institute of Cancer Research
    摘要: Introduction and objectives: The aim of the study is to analyze the treatment patterns of non-metastatic prostate cancer in Taiwan, a highly-developed Asian country with a very unique national healthcare system covered near 100% of the national population. Materials and methods: Analyses were made from 64 high-volume hospitals with data contributed to the National Cancer Registry Database, Taiwan from 1998 – 2012, which represented > 70% of annual prostate cancer patients. Patients with localized (stage I-II, AJCC 7th ed., 2002) or locally advanced (AJCC stage III) prostate cancer were further investigated. The distribution of primary treatment modalities was measured. The descriptive analysis was performed. The patterns of treatment were compared between patients younger or older than 75 years and hospitals with patient numbers less or more than 250 from 1998 – 2012. The annual trends of the treatment patterns were also investigated. Results: In total, 10 050 patients were analyzed in the 5 year period with 8115 (80.7%) localized and 1935 (19.3%) locally advanced disease. The treatment modalities were 2971 (29.6%) external-beam radiation (EBT), 2782 (27.7%) radical prostatectomy (RP), 2504 (24.9%) primary hormonal therapy (PHT), 870 (8.7%) transurethral resection of prostate (TURP) only, 404 (4.0%) watchful waiting (WW), and 399 (4.0%) cryoablation. Among patients with localized disease, 26.4% elected EBT, 29.2% RP, 24.7% PHT, 10.4% TURP only, 4.6% WW, and 3.3% cryoablation. For those with locally advanced disease, 42.8% elected EBT, 21.1% RP, 26.0% PHT, 1.2% TURP only, 1.3% WW, and 6.9% cryoablation. There are signi fi cant differences (P < 0.0001) between the main treatment modalities between localized and locally advanced disease except PHT. After stratifying patients by age (cutoff of 75 years) and patient volume (cutoff of 250 cases in 5 years), signi fi cant differences were observed between the main treatment choices including RP, EBT, PHT, TURP only, and WW forlocalized disease. The differences were signi fi cant in RP, PHT, cryoablation between patients younger or older than 75 years and RP, EBT, PHT, and cryoablation between hospitals with patient numbers less or more than 250 for locally advanced disease. Conclusion: In this Asian country with a very high accessibility of healthcare system, the choices of treatment modalities for localized and locally advanced disease were significantly different. Age and patient volumes were important determining factors for the treatment choices of both localized and locally advanced prostate cancer. Such information was invaluable in the Asian society which would provide valuable references.
    日期: 2017-07-31
    關聯: International Journal of Urology. 2017 Jul 31;24(Suppl. S1):98.
    Link to: http://dx.doi.org/10.1111/iju.13413
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0919-8172&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000406683600274
    顯示於類別:[劉滄梧] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000406683600274.pdf38KbAdobe PDF511檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋